Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Multiplace Series
Hard-Shell Multiplace·2-18+ person
Pressure3 ATA
$150,000 - $400,000+
●●●○Moderate Evidence
Hyperbaric Therapy for Post-Concussion Syndrome
Multiple RCTs show cognitive, sleep, and headache improvements in mTBI patients — with ongoing $28M veterans trial at USF.
Hyperbaric oxygen therapy (HBOT) for Post-Concussion Syndrome has moderate clinical evidence. This is currently an off-label use and is not covered by insurance. The recommended protocol is 1.5 ATA ATA for 60 minutes per session per session over 40 sessions sessions.
Key Takeaways
- 40-session protocol at 1.5 ATA showed significant cognitive improvement in RCT of 56 mTBI patients (Boussi-Gross 2013)
- Brain perfusion imaging (SPECT) confirmed improved blood flow to hypoperfused regions after HBOT
- USF received $28M federal funding (2025) for the largest veterans HBOT-TBI trial to date
- 1.5 ATA is used specifically — lower pressure reduces oxygen toxicity risk in injured brains
- Improvements documented in attention, memory, executive function, headache severity, and sleep
What is Post-Concussion Syndrome?
Post-concussion syndrome (PCS) refers to a cluster of symptoms — headaches, cognitive fog, sleep disruption, irritability, and fatigue — that persist for weeks, months, or years after a concussion. The underlying mechanism is believed to involve microstructural brain damage, neuroinflammation, and impaired cerebral blood flow in regions that appear normal on standard MRI. These "hypoperfused" zones are thought to contain neurons that are damaged but not dead — potentially recoverable with the right intervention. Hyperbaric oxygen therapy has emerged as one of the more promising treatments for PCS, particularly in the military population where blast-related mTBI is widespread. Multiple randomized controlled trials have demonstrated improvements in cognitive function, headache severity, sleep quality, and quality of life following HBOT protocols. The USF Comprehensive Center for Brain Health received $28 million in federal funding in 2025 to conduct the largest veterans HBOT trial to date, reflecting the growing institutional momentum behind this indication. HBOT for post-concussion syndrome is currently off-label in the United States. It is not FDA-approved for this use. However, the body of evidence is substantial enough that many functional medicine and sports medicine physicians prescribe it off-label, and a number of military treatment facilities offer it to veterans.
How Hyperbaric Therapy Helps Post-Concussion Syndrome
The primary mechanism involves restoration of oxygen delivery to hypoperfused brain regions — areas with inadequate blood flow that standard imaging often misses. Under hyperbaric conditions, dissolved oxygen in plasma increases dramatically, bypassing hemoglobin and reaching ischemic tissue directly. This triggers several cascading effects: upregulation of hypoxia-inducible factor (HIF) pathways that stimulate angiogenesis (new blood vessel formation), increased vascular endothelial growth factor (VEGF) production promoting revascularization, reduction of neuroinflammation through decreased microglial activation and pro-inflammatory cytokines, and enhanced neuroplasticity. The net effect is that dormant or injured neurons in the concussion penumbra may recover function — explaining the cognitive improvements documented in RCTs. Lower pressures (1.5 ATA) are specifically used rather than higher pressures to avoid oxygen toxicity in a brain that may already be vulnerable.
Recommended Protocol
Pressure
1.5 ATA
Sessions
40 sessions
Duration
60 minutes per session
What Does the Evidence Say?
●●●○Moderate Evidence
Boussi-Gross et al. (2013) published the landmark RCT in PLOS ONE: 56 mTBI patients with persistent PCS at least 1 year post-injury were randomized to 40 sessions of HBOT at 1.5 ATA/100% O2 vs. a crossover control. The HBOT group showed significant improvements in cognitive function (attention, memory, executive function) and quality of life, with corresponding improvements on brain perfusion imaging (SPECT). Wolf et al. (2012) conducted a military RCT showing meaningful improvements in cognitive domains and PTSD symptoms. The ongoing USF study ($28M, launched 2025) is the largest to date and will provide the most definitive evidence. Limitations: studies have small sample sizes, outcome measures vary, and blinding is challenging in HBOT research. HBOT at 1.5 ATA is generally considered lower-risk than higher pressure protocols, which matters when treating brain injuries.
Off-Label Use
Post-Concussion Syndrome is not an FDA-approved indication for HBOT. Treatment is considered off-label and is typically not covered by insurance. Consult your physician before starting any HBOT protocol.
Recommended Chambers for Post-Concussion Syndrome
Based on the protocol requirements — minimum 1.5 ATA, Clinical Grade tier. Sorted by clinical credibility score.
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 34
Hard-Shell Monoplace·1-person
Pressure3 ATA
$50,000 - $90,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 36
Hard-Shell Monoplace·1-person
Pressure3 ATA
$55,000 - $95,000
Clinical GradeFDA Cleared
For Maximum Comfort
Perry Baromedical
Sigma 40
Hard-Shell Monoplace·1-person
Pressure3 ATA
$65,000 - $110,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma 40-II
Hard-Shell Multiplace·2-person
Pressure3 ATA
$100,000 - $160,000
Clinical GradeFDA Cleared
For Wound Care
Perry Baromedical
Sigma Elite
Hard-Shell Monoplace·1-person
Pressure3 ATA
$80,000 - $130,000
Frequently Asked Questions
What is the difference between post-concussion syndrome and traumatic brain injury (TBI)?
TBI is the injury event and its immediate neurological consequences — ranging from mild (concussion) to severe. Post-concussion syndrome is a specific outcome of mild TBI where symptoms persist beyond the expected recovery window (typically 3 months). Most TBI research involves moderate-to-severe injuries; PCS research focuses specifically on the chronic symptom burden after mild injuries. Both are studied with HBOT, but protocols and evidence differ — PCS typically uses 1.5 ATA, while severe TBI may use different parameters.
How long until I notice improvements from HBOT for post-concussion syndrome?
In the Boussi-Gross RCT, measurable cognitive improvements appeared within the 40-session protocol (approximately 2 months of daily sessions). Many patients report subjective improvements in headaches and sleep within the first 10–20 sessions. Neuroplasticity changes continue post-treatment as the brain consolidates structural improvements. Individual variation is significant — some patients with long-standing PCS (5+ years) have responded well, while others see minimal benefit.
Can I use a soft-shell chamber or a 1.3 ATA home chamber for post-concussion syndrome?
The published research used 1.5 ATA with 100% oxygen — parameters that require a clinical-grade hard-shell chamber. Soft-shell chambers typically reach 1.3 ATA and use filtered ambient air (approximately 21% oxygen), not pure oxygen. This means they deliver roughly one-fifth the dissolved oxygen of a clinical protocol. There is no published RCT evidence for 1.3 ATA air in PCS. If clinical access is unavailable, some practitioners use advanced-wellness hard-shell chambers at 1.5 ATA with oxygen concentrator, but this is not the studied protocol.
Does insurance cover HBOT for post-concussion syndrome?
Generally no — HBOT for PCS is off-label and most commercial insurers and Medicare do not cover it for this indication. Veterans may have more options through the VA, and the growing body of military research is driving policy conversations. Out-of-pocket costs typically run $150–$350 per session at clinical facilities, making a 40-session protocol $6,000–$14,000. Some clinical trials (including the USF study) offer free treatment for qualifying veterans.
Is the USF veterans HBOT trial currently enrolling?
The University of South Florida's Comprehensive Center for Brain Health received $28 million in federal funding in 2025 for a large-scale HBOT veterans trial. As of 2025, enrollment was underway. Visit the USF Health website or ClinicalTrials.gov and search 'hyperbaric oxygen traumatic brain injury' for current enrollment status. Qualifying veterans may receive free treatment as trial participants.
Related Conditions
Sources & References
- Boussi-Gross et al. (2013) — Hyperbaric Oxygen Induces Late Neuroplasticity in Post Stroke Patients—Randomized, Prospective Trial, PLOS ONE
- Wolf et al. (2012) — Randomized Prospective Trial of Hyperbaric Oxygen for Chronic Baseline Neuropsychological Dysfunction in Mild Traumatic Brain Injury, Military Medicine
- USF Health (2025) — Veterans Powering Landmark Hyperbaric Oxygen Research ($28M trial)
- Harch et al. (2012) — A Phase I Study of Low-Pressure Hyperbaric Oxygen Therapy for Blast-Induced Post-Concussion Syndrome and PTSD, Journal of Neurotrauma
Last updated: March 2026. Data sourced from manufacturer specifications, FDA databases, and published clinical research.
Ready to compare chambers?
Use our filterable directory to find chambers that match your protocol requirements.